Skip to main content
OpenTrials

Clinical trial condition

Stomach Diseases

Explore clinical trials studying Stomach Diseases. Study availability and eligibility vary by location and protocol.

2,578 public trials 586 recruiting studies
Refine in advanced search Browse all conditions

Stomach Diseases trial results

Active, Not Recruiting

Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma

NCT05539430

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +16 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating Bemarituzumab in Combination With Other Anti-cancer Therapies in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer.

NCT05322577

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastric Cancer, +7 more
Locations
  • Northport Veterans Affairs Medical Center Northport, New York, United States
  • Fujita Health University Hospital Toyoake-shi, Aichi-ken, Japan
  • Hirosaki University Hospital Hirosaki-shi, Aomori, Japan
  • Chiba University Hospital Chiba, Japan
View all 42 locations
View Trial Details
Active, Not Recruiting

A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05238883

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +57 more
Locations
  • Mayo Clinic Scottsdale, Arizona, United States
  • USC/Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • Mayo Clinic Rochester, Minnesota, United States
View Trial Details
Active, Not Recruiting

Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression

NCT04180371

Conditions
Adnexal Diseases, Advanced Solid Tumor Historically Known for High EphA2 Expression, Breast Diseases, +49 more
Locations
  • California Cancer Associates for Research and Excellence, Inc. Encinitas, California, United States
  • University of California - Irvine Medical Center Orange, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 28 locations
View Trial Details
Active, Not Recruiting

Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors

NCT06714617

Conditions
Adnexal Diseases, Breast Cancer Stage III, Breast Diseases, +48 more
Locations
  • SCRI-Denver HealthOne Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • SCRI-Florida Cancer Center Specialists Lake Mary Lake Mary, Florida, United States
  • Hematology Oncology Associates of the Treasure Cost Port Saint Lucie, Florida, United States
View Trial Details

Related conditions